In the October issue of JNNP, Lin and colleagues explore plasma levels of a-synuclein as a biomarker in patients with varying stages of Parkinson’s disease (PD), across both motor and non-motor domains.The extensive evaluation of biofluids in the hunt for diagnostic and prognostic biomarkers in PD has been disappointing and largely inconclusive to date. Studies […]